C Mircea S Tesileanu

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 7

Top Topics

Chronic Myeloid Leukemia

Placebo Controlled

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Clinical pharmacology and therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

C Mircea S Tesileanu, Francesco Pignatti, Enrico Tognana, Anthony Humphreys
Queries raised during oncology business pipeline meetings at the European Medicines Agency: a 5-year retrospective analysis. Clinical pharmacology and therapeutics (2023)
C Mircea S Tesileanu, Sotirios Michaleas, Rocio Gonzalo Ruiz, Segundo Mariz, Babs O Fabriek, Paula B van Hennik, Jutta Dedorath, Bruna Dekic, Christoph Unkrig, Andreas Brandt, Janet Koenig, Harald Enzmann, Julio Delgado, Francesco Pignatti
The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With At Least 2 Tyrosine Kinase Inhibitors. The oncologist (2023)
Mark P van Opijnen, C Mircea S Tesileanu, Linda Dirven, Pim B van der Meer, Maarten M J Wijnenga, Arnaud J P E Vincent, Marike L D Broekman, Hendrikus J Dubbink, Johan M Kros, Sjoerd G van Duinen, Marion Smits, Pim J French, Martin J van den Bent, Martin J B Taphoorn, Johan A F Koekkoek
IDH1/2 wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared to IDH1/2 wildtype glioblastomas. Neuro-oncology (2022)
C Mircea S Tesileanu, Marc Sanson, Wolfgang Wick, Alba A Brandes, Paul M J Clement, Sara C Erridge, Michael A Vogelbaum, Anna K Nowak, Jean-Francois Baurain, Warren P Mason, Helen Wheeler, Olivier Louis Chinot, Sanjeev Gill, Matthew Griffin, Leland Rogers, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Myra E van Linde, Kenneth D Aldape, Robert B Jenkins, Johan M Kros, Pieter Wesseling, Andreas von Deimling, Youri Hoogstrate, Iris de Heer, Peggy N Atmodimedjo, Hendrikus Jan Dubbink, Rutger W W Brouwer, Wilfred F J Van IJcken, Kin Jip Cheung, Vassilis Golfinopoulos, Brigitta G Baumert, Thierry Gorlia, Pim J French, Martin J Van Den Bent
Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (12) (2022)
Kaspar Draaisma, C Mircea S Tesileanu, Iris de Heer, Martin Klein, Marion Smits, Jaap C Reijneveld, Paul M J Clement, Filip Yves Francine De Vos, Antje Wick, Paul J Mulholland, Martin J B Taphoorn, Michael Weller, Olivier Louis Chinot, Johan M Kros, Tina Verschuere, Corneel Coens, Vassilis Golfinopoulos, Thierry Gorlia, Ahmed Idbaih, Pierre A J T Robe, Martin J Van Den Bent, Pim J French
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial. Clinical cancer research : an official journal of the American Association for Cancer Research 28 (11) (2022)
C Mircea S Tesileanu, Thierry Gorlia, Vassilis Golfinopoulos, Pim J French, Martin J Van Den Bent
MGMT promoter methylation determined by the MGMT-STP27 algorithm is not predictive for outcome to temozolomide in IDH-mutant anaplastic astrocytomas. Neuro-oncology 24 (4) (2022)
C Mircea S Tesileanu, Martin J Van Den Bent, Marc Sanson, Wolfgang Wick, Alba A Brandes, Paul M Clement, Sara C Erridge, Michael A Vogelbaum, Anna K Nowak, Jean F Baurain, Warren P Mason, Helen Wheeler, Olivier L Chinot, Sanjeev Gill, Matthew Griffin, Leland Rogers, Walter Taal, Roberta Rudà, Michael Weller, Catherine McBain, Myra E van Linde, Thais S Sabedot, Youri Hoogstrate, Andreas von Deimling, Iris de Heer, Wilfred F J van IJcken, Rutger W W Brouwer, Kenneth Aldape, Robert B Jenkins, Hendrikus J Dubbink, Johan M Kros, Pieter Wesseling, Kin Jip Cheung, Vassilis Golfinopoulos, Brigitta G Baumert, Thierry Gorlia, Houtan Noushmehr, Pim J French
Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. Neuro-oncology 23 (9) (2021)